Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition (PDF) ...

Sun Pharma will acquire 100% of Organon’s outstanding equity at an enterprise value of $11.75 billion, the company said. ...

Organon & Co. OGN said on Sunday it signed a definitive agreement to be acquired by Sun Pharmaceutical Industries in an ...

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

The deal values Organon at about $11.75 billion and is expected to close in early 2027. ・The acquisition boosts Sun Pharma’s footprint across women’s health, biosimilars, and established branded ...

Organon & Co is listed on NYSE and specialises in core therapeutic fields: reproductive medicine, contraception, psychiatry, ...

Sun Pharma share price surged 5% on Monday after the acquisition of US-based Organon. Here's all the details about the deal, ...

Organon (OGN) stock jumped 46% after Sun Pharmaceutical agreed to acquire the company for $11.75B in cash at $14/share, ...

Sun Pharma to buy Organon in $11.75 billion all-cash deal at $14 per share. Deal boosts presence in women’s health, ...

From nearly doubling EBITDA to becoming a top player in biosimilars and women’s health, here are five key takeaways investors ...

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, ...

Sun Pharma shares jumped 9% after India’s largest drugmaker by market value announced an all-cash $11.75 billion acquisition ...